TARGET BP I Clinical Trial
Clinical trial NCT02910414 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02910414
- Sponsor
- Ablative Solutions, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2023-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.